Canadian agrochem raises $45 million for technology to reduce the use of chemicals in agriculture

September 6, 2019

article image
Terramera, a Canadian company selling bio-pesticides and seed treatments to reduce the use of chemicals in agriculture, has raised $45 million in its latest round of financing. The round was led by strategic investor Ospraie Ag Science and the company’s previous backer, Seed2Growth Ventures. Led by Carl Casale, a former Monsanto executive, Ospraie Ag Science has backed several manufacturers of bio-pesticides and organic crop management products including Marrone BioInnovations and Agrospheres. Vancouver-based Terramera first came to prominence with a line of Neem (Azadirachta indica)-based pesticides that are sold in retailers across North America (including Target). That product targets bedbugs, mites, and other household pests and funguses. The company’s latest product is Actigate, and capital from its latest round will be used to boost research and development and sales and marketing, according to a statement.

Spotlight

Amneal Pharmaceuticals

Amneal Pharmaceuticals is the fifth largest generic pharmaceutical manufacturer in the United States and the fastest growing generic company globally, according to IMS Health. Founded in 2002 in the United States by brothers Chirag and Chintu Patel, the company has since grown to include offices in Australia, Europe and Asia. Amneal’s diversified portfolio includes high quality complex dosage forms, such as liquids, topicals, transdermals, injectables, and inhalation products. As Amneal continues to experience unprecedented growth, its focus on quality, superb service levels, and building strong relationships holds firm and stands as testament to the strength of its reputation.

OTHER ARTICLES

Transporting biological and chemical materials - what you need to know

Article | February 13, 2020

The landscape of biological and chemical logistics has changed rapidly - as have the regulatory frameworks around it. What has not necessarily kept pace is the end-user understanding of the nature of these logistical processes, their opportunities and their constraints. Twenty years ago, the transmission of biological and chemical materials was limited to a small range of organisations: usually national and international research companies, hospitals, major university departments, police and military departments with forensic responsibilities.

Read More

Setting record straight on testing harm in chemicals

Article | February 13, 2020

The modern world is built on chemicals, be it the medicines we use, or cleaning fluids, crop protection products, or the raw materials for everything from laptops and mobile phones to clothes and furniture. Across all, we have created an entire modern society with chemicals, and, as a result, constantly stretched the size of the world population we can feed, clothe and shelter. Yet, balancing all the gains from the modern chemistry around us against any negative environmental and human impact has been a rising concern, making for ever greater focus on testing and on risk assessment.

Read More

Why chemical characterization is the best way to assess patient risk

Article | February 11, 2020

Everyone is very familiar with the phrase when buying a house: All that really matters are three things - location, location, and location. This same principle applies to extractables and leachables chemistry analysis – the three things that truly matter are identification, identification, and identification. The greatest growth in the past ten years in demonstrating the safety of medical devices and container closure systems for drugs has been using analytical chemistry to determine what chemicals can leach from the device and what the patient is exposed to during its intended use.

Read More

How Chemical Companies Benefit from the Experience Economy

Article | February 10, 2020

To feel or experience from a business engagement started with customer experience mainly in the consumer products business. Today it has extended to even knowledge industries like the chemical industry where experiencing or feeling can be leveraged to include all stake holders from customers primarily to employees to supply chain people & suppliers and all else. With digital technologies this has become easier than before. The benefits from promoting the ‘feel’ or ‘experience’ emotion could be multifarious for the chemical industry as described in this article.

Read More

Spotlight

Amneal Pharmaceuticals

Amneal Pharmaceuticals is the fifth largest generic pharmaceutical manufacturer in the United States and the fastest growing generic company globally, according to IMS Health. Founded in 2002 in the United States by brothers Chirag and Chintu Patel, the company has since grown to include offices in Australia, Europe and Asia. Amneal’s diversified portfolio includes high quality complex dosage forms, such as liquids, topicals, transdermals, injectables, and inhalation products. As Amneal continues to experience unprecedented growth, its focus on quality, superb service levels, and building strong relationships holds firm and stands as testament to the strength of its reputation.

Events